Strata Critical Medical, Inc.
SRTA
$5.43
-$0.06-1.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.89% | 35.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.89% | 35.48% | |||
| Cost of Revenue | -3.36% | 46.26% | |||
| Gross Profit | 20.97% | 0.48% | |||
| SG&A Expenses | 3.93% | 19.15% | |||
| Depreciation & Amortization | -42.93% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.51% | 41.06% | |||
| Operating Income | 46.58% | -518.02% | |||
| Income Before Tax | 144.58% | 44.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 144.58% | 44.21% | |||
| Earnings from Discontinued Operations | 92.80% | -105.14% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 124.39% | -115.38% | |||
| EBIT | 46.58% | -518.02% | |||
| EBITDA | 306.99% | -253.16% | |||
| EPS Basic | 124.16% | -114.98% | |||
| Normalized Basic EPS | 101.79% | -354.55% | |||
| EPS Diluted | 124.16% | -115.04% | |||
| Normalized Diluted EPS | 101.79% | -354.55% | |||
| Average Basic Shares Outstanding | 0.74% | 2.72% | |||
| Average Diluted Shares Outstanding | 6.46% | 2.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||